MedTrace Logo

Prognosis of SRD Patients in the ICU

NCT04398381 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 525

Last updated 2020-05-28

No results posted yet for this study

Summary

Critically ill systemic rheumatic disease (SRD) patients have benefited from better provision of rheumatic and critical care in recent years. Recent comprehensive data regarding in-hospital mortality and most importantly long-term outcome are scarce. The aim of this study is to assess short and long-term outcome of patients with SRD admitted to the ICU in a retrospective cohort study (2006 - 2016).

Conditions

  • Systemic Rheumatic Diseases
  • Intensive Care Unit
  • Corticosteroids

Sponsors & Collaborators

  • Groupe Hospitalier Pitie-Salpetriere

    collaborator OTHER

  • Sorbonne University

    collaborator OTHER

  • Hôpital Lariboisière Fernand Widal

    collaborator OTHER

  • Université Montpellier

    collaborator OTHER

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • Romaric Larcher, MD PhD · UH Montpellier

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-01
Primary Completion
2019-06-01
Completion
2019-06-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04398381 on ClinicalTrials.gov